Skip Navigation

A Phase Ib/II Trial of Zunsemetinib in Combination with Capecitabine in Patients with Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer with Bone Metastasis

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT06374459

Study #:
STUDY00161889

Start Date:
Feb 06, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06374459

View Complete Trial Details & Eligibility at ClinicalTrials.gov